The present invention is directed to a device for delivery of medicament, and in particular to a compact jet injector and loading system used with standard medicament cartridges.
A wide variety of needle tree injectors are known in the art. Examples of such injectors include those described in U.S. Pat. No. 5,599,302 issued to Lilley et al., U.S. Pat. No. 5,062,830 to Dunlap, and U.S. Pat. No. 4,790,824 to Morrow et al. In general, these and similar injectors administer medication as a fine, high velocity jet delivered under sufficient pressure to enable the jet to pass through the skin.
Although these injectors are quite successful from a technical point-of-view in achieving the desired delivery of medicament, most commercially available needle tree injectors have practical limitations. For example, most needle free injectors are bulky in size. In addition to the undesirable size, some needle tree injectors require a complex sequence of coupling and uncoupling the injector to a vial containing the medicament. Thus, there is a perception by the user that the injector is difficult to use. Finally, some needle tree injectors cannot be used with standard medicament cartridges, i.e. a cylindrical chamber, typically made of glass, having a first end with a seal penetrable by a needle to draw medicament out of the cartridge and a second end with a movable stopper.
Thus, there exists a need for an improved medical injector and loading system that is compact, usable with standard medicament cartridges, and perceived as easy to operate.
The present invention is directed to a cap for a medicament cartridge. The cartridge has a chamber containing medicament, a first end of the chamber having a seal, and a second end of the chamber having a stopper movable towards the seal as medicament is drawn out of the chamber. The cap according to the present invention comprises an interior portion for receiving the second end of the chamber and a post for causing movement of the stopper toward the seal when the cap engages the medicament cartridge to thereby eliminate adhesion between the chamber and the stopper.
The adhesion-eliminating cap can be used in combination with an adapter for transfer of medicament out of the cartridge. The action of the cap in conjunction with the adapter is to allow the purging of gas or air from the cartridge and thus assist in better dosage accuracy and injection quality. The adapter has a first side that mates with the first end of the chamber and has a needle for penetrating the seal upon insertion of the cartridge assembly in the adapter, a second side, and a wall between the first and second sides. The wall has an opening in fluid communication with the needle to create a pathway for medicament as medicament is drawn out of the chamber. Preferably, the first side of the adapter has a plurality of resilient tabs that flex outward upon insertion of the medicament cartridge into the adapter and flex inward after the seal is substantially flush with the wall for locking the medicament cartridge into the adapter.
In one embodiment, the cap and adapter are coupled with a housing. The housing has a first end connectable with the cap and a second end connectable with the adapter. The housing can include a window for visualization of at least a portion of the medicament cartridge.
The cap according to the present invention can be used with a wide variety of injection devices, including a needle free injector. Preferably, the needle free injector comprises a needle free syringe assembly and a power pack assembly. The needle free syringe assembly includes a nozzle member defining a fluid chamber and having a proximal end that mates with the second side of the adapter. The needle free syringe assembly also includes a plunger movable in the fluid chamber. The power pack assembly includes a housing having a proximal end connectable with the distal end of the nozzle member, a trigger assembly, and an energy source operatively associated with the trigger assembly. Movement of the trigger assembly activates the energy source to move the plunger in a first direction to expel medicament from the fluid chamber when the adapter is not connected to the needle free syringe assembly and movement of the plunger in a second direction draws medicament out of the cartridge chamber and into the fluid chamber when the adapter is connected to the needle free syringe assembly.
In one embodiment, the first end of the cartridge assembly housing has a female thread and the cap has a collar insertable into the first end of the cartridge housing. The collar is provided with a male thread that mates with the female thread for connection of the housing with the cap.
The present invention can be used with lyophilized medicament. Specifically, the medicament chamber has a first chamber containing a lyophilized medicament, a second chamber containing a reconstituting fluid, a dividing member separating the first and second chambers, and a bypass channel for providing fluid communication between the first and second chambers upon movement of the dividing member. Fluid pressure generated by movement of the stopper causes movement of the dividing member. The attached adapter assembly allows the venting of the gas or air from the first chamber thereby facilitating dividing member movement and fluid flow. This also allows minimizing the air or gas present in the reconstituted fluid prior to injection.
The present invention is also directed to a medical injector assembly comprising a cartridge assembly for holding a medicament cartridge and a syringe assembly. The medicament cartridge has a chamber containing medicament, a first end of the chamber with a seal, and a second end of the chamber with a stopper movable towards the seal as medicament is drawn out of the chamber. The cartridge assembly comprises a cap with an interior for receiving the second end of the chamber and an end having a post causing movement of the stopper toward the seal as the medicament cartridge is inserted in the cap to thereby eliminate adhesion between the chamber and the stopper. The syringe assembly comprises a fluid chamber, a needle, and a plunger. The plunger is movable in the fluid chamber so that movement in the first direction expels medicament from the fluid chamber. Movement of the plunger in the second direction draws medicament out of the cartridge chamber into the fluid chamber when the syringe assembly is in fluid communication with the medicament cartridge. In one embodiment describing such fluid communication, the needle on the syringe assembly penetrates the seal on the first end of cartridge chamber. Another embodiment anticipates a receiving member for the syringe needle in the adapter. The seal penetrating needle in this embodiment is integral to a first side of the adapter (the side that mates with the first end of the cartridge chamber). The second side of the adapter consists of a receiving member for the syringe and syringe needle designed as to allow fluid communication with the first side of the adapter.
As shown in
The first step in assembling cartridge assembly 12 is to couple medicament cartridge 18 with adapter 20. Adapter 20 has a first side 30 configured and dimensioned to mate with the end of medicament cartridge 18 that has seal 26 and a second side 32 configured and dimensioned to mate with needle free syringe assembly 14. Second side 32 can have a barrier with a so-called “zero diameter” hole or slit to minimize the potential for leakage and potential of contamination. As disclosed in U.S. Pat. No. 5,846,233, the disclosure of which is incorporated herein by reference, such a hole or slit only allows passage of fluid when stretched, i.e. when needle free syringe assembly 14 is mated to second side 32.
First side 30 also includes a frangible retaining member such as resilient tabs 39 that flex outward upon insertion of medicament cartridge 18 into adapter 20 and flex back inward after seal 26 is substantially flush with wall 34 to lock the medicament cartridge 18 into adapter 20. Because tabs 39 must be broken to remove medicament cartridge 18, tabs 39 help ensure that adapter 20 is disposed of after use and not reused with multiple medicament cartridges.
The next step in assembling cartridge assembly 12 is to attach cap 22 to medicament cartridge 18. As shown in
The final step in assembling cartridge assembly 12 is to connect cap 22 to cartridge housing 24. As shown in
Prior to connecting cartridge assembly 12 and power pack assembly 16, needle free syringe assembly 14 must be attached to power pack assembly 16. FIGS. 1 and 8-11 show that needle free syringe assembly 14 includes a nozzle member 60 and a plunger 62. Nozzle member 60 includes a cylindrical fluid chamber 64 terminating at one end in a cone 66 and at the other end in an expanded area tail 68. Cone 66 can be a convex cone (as shown), a right circular cone, or any other suitable configuration. Cone 66 leads to an orifice 69 of a suitable diameter that would produce a jet stream of medicament under a given desired pressure range and depth of injection. Plunger 62 has a pressure wall 70 contoured to cone 66 and is positioned to slide within fluid chamber 64. Plunger 62 also includes a series of ridges 72 formed around its outer periphery to provide a seal and create a sterile boundary between the medicament and the outside of the nozzle member 60. As described in more detail below, legs 74 of plunger 62 compress around a ram 76 to operatively couple plunger 62 to ram 76. Legs 74 are resilient and ordinarily biased outward. However, the relative size of fluid chamber 64 keeps legs 74 compressed inward against ram 76 to maintain the coupling. When needle free syringe assembly 14 is removed from power pack assembly 16, legs 74 expand out into the expanded area of tail 68 so that plunger 62 remains with nozzle member 60. Thus, all of needle free assembly 14 can be disposed of after the prescribed number of injections.
A proximal end 78 of nozzle member 60 has a taper that matches that of adapter second side 32 so that when proximal end 78 is inserted into adapter second side 32, fluid chamber 64 is in fluid communication with needle 36 and channel 38 to allow transfer of medicament from medicament cartridge 18 into fluid chamber 64. A distal end 80 of nozzle member 60 has locking tabs 82 and each locking tab 82 is provided with a recess 84. Locking tabs 82 and recess 84 mate with corresponding features on power pack assembly 16 to lock needle free syringe assembly 12 to power pack assembly 16. These and other structural features of power pack assembly 16 will now be described.
Power pack assembly 16 has a two part housing that includes a proximal housing 86 (
The outer surface of proximal housing 86 is provided with cut outs 96, which are mirror images of markings 56 on cartridge housing 24 to ensure proper alignment of cartridge assembly 12 and power pack assembly 16. Cut outs 96 also function to allow viewing of medicament once it has been drawn into needle free syringe assembly 14. The outer surface of proximal housing 86 is also provided with threads 98 and the inner surface of distal housing 88 is provided with threads 100 so that when proximal, housing 86 is inserted in distal housing 88, threads 98 mate with threads 100. As described in more detail below, the relative motion between proximal and distal housings 86, 88 allow arming and dosing of medical injector 10.
Indicia 102 on exterior of proximal housing 86 are for determining the dose of medicament to be injected and grooves 104 provide tactile and audible feedback of dosage of medicament. Specifically, only one of the numbers of indicia 102 is viewable through dosing window 106 located on distal housing 88. As distal housing 88 is rotated counterclockwise relative to proximal housing 86, the number viewable in dosing window 106 increases to reflect a higher dose. A proximal end of distal housing 88 has protuberances 108 for receiving slots 110 of a dosing detent 112 (
A distal end of distal housing 88 has crush ribs 120 for providing an interference fit with a button cap 122 (
As previously noted, plunger 62 is connected to ram 76. This connection forms when needle free syringe assembly 14 is coupled to power pack assembly 16. Specifically, as nozzle member 60 is inserted in proximal housing 86, a proximal end 130 of ram 76 (
Medical injector 10 includes a trigger assembly for firing power pack assembly 16. Two exemplary embodiments of a trigger assembly are now described. In the first, the trigger assembly includes a latch spring 142 (
When button 144 is depressed, area 174 on stem 170 of button 144 lines up with holes 168 in latch housing 148. This allows energy source 134 to force ram 76 away from latch housing 148, thereby pushing latch balls 166 into area 174 on stem 170. This is referred to as the fired position and is best seen in
The operation of medical injector 10 will now be described, with a just-fired injector as the starting point and with reference to the first-described trigger assembly. In order to re-arm injector 10, the user rotates distal housing 88 clockwise with respect to proximal housing 86 to compress energy source 134 between ridge 158 of latch housing 148 and disk 138 of ram 76. The rotation continues until latch spring 142 is retained within keyed area 160 to thereby keep energy source 134 compressed. Medicament is drawn into fluid chamber 64 by counterclockwise rotation of distal housing 88 with respect to proximal housing 86, thus aspirating the fluid. Specifically, the rotation causes distal movement of ram 76 and plunger 62 (because ram 76 is locked to distal housing 88), which in turn creates a vacuum in fluid chamber 64 to draw medicament through medicament cartridge 18 and adapter 20 and into fluid chamber 64. In order to fire injector 10, cartridge assembly 12 is removed from needle free assembly 14 and the proximal end of needle free syringe assembly 14 is placed against the skin at the desired injection site. Button 144 is depressed to disengage latch spring 142 from keyed area 160. This allows energy source 134 to return to its uncompressed state and move ram 76 and plunger 62 proximally so that medicament is ejected through orifice 69 at a pressure sufficient to jet inject the medicament.
As is evident from the description of the structure and operation of medical injector 10, injector 10 is a compact injector that is convenient to transport. Injector 10 is also simple to use and operate. In particular, injector 10 is ready to be loaded every time cartridge assembly 12 is placed on needle free syringe assembly 14.
The three assembly (cartridge, needle free syringe, and power pack) design allows an individual assembly to be modified without affected the other two assemblies. For example,
While it is apparent that the illustrative embodiments of the invention herein disclosed fulfill the objectives stated above, it will be appreciated that numerous modifications and other embodiments may be devised by those skilled in the art. Therefore, it will be understood that the appended claims are intended to cover all such modifications and embodiments which come within the spirit and scope of the present invention.
This application is a continuation of U.S. patent application Ser. No. 09/692,487, filed on Oct. 20, 2000 now U.S. Pat. No. 6,673,035, which claims the benefit of U.S. Provisional Application No. 60/160,893 filed on Oct. 22, 1999 under 35 U.S.C. §119(e). The entire content of both of these applications is hereby incorporated herein by reference thereto.
Number | Name | Date | Kind |
---|---|---|---|
1512294 | Marcy | Oct 1924 | A |
1687323 | Cook | Oct 1928 | A |
2354649 | Bruckner | Aug 1944 | A |
2607344 | Brown | Aug 1952 | A |
2645223 | Lawshe et al. | Jul 1953 | A |
2648334 | Brown et al. | Aug 1953 | A |
2699166 | Dickinson, Jr., et al. | Jan 1955 | A |
2717601 | Brown | Sep 1955 | A |
3557784 | Shields | Jan 1971 | A |
3770026 | Isenberg | Nov 1973 | A |
3811441 | Sarnoff | May 1974 | A |
4171698 | Genese | Oct 1979 | A |
4328802 | Curley et al. | May 1982 | A |
4333458 | Margulies et al. | Jun 1982 | A |
4338980 | Schwebel et al. | Jul 1982 | A |
4936833 | Sams | Jun 1990 | A |
4973318 | Holm et al. | Nov 1990 | A |
5137528 | Crose | Aug 1992 | A |
5226895 | Harris | Jul 1993 | A |
5232459 | Hjertman | Aug 1993 | A |
5256142 | Colavecchio | Oct 1993 | A |
5279585 | Balkwill | Jan 1994 | A |
5279586 | Balkwill | Jan 1994 | A |
5281198 | Haber et al. | Jan 1994 | A |
5292318 | Haber et al. | Mar 1994 | A |
5308341 | Chanoch | May 1994 | A |
5330431 | Herskowitz | Jul 1994 | A |
5542760 | Chanoch et al. | Aug 1996 | A |
5573042 | De Haen | Nov 1996 | A |
5599302 | Lilley et al. | Feb 1997 | A |
5649912 | Peterson | Jul 1997 | A |
5658259 | Pearson et al. | Aug 1997 | A |
5688251 | Chanoch | Nov 1997 | A |
5704911 | Parsons | Jan 1998 | A |
5725508 | Chanoch et al. | Mar 1998 | A |
5769138 | Sadowski et al. | Jun 1998 | A |
5788670 | Reinhard et al. | Aug 1998 | A |
5807309 | Lundquist et al. | Sep 1998 | A |
5827232 | Chanoch et al. | Oct 1998 | A |
5851198 | Castellano et al. | Dec 1998 | A |
5860456 | Bydlon et al. | Jan 1999 | A |
5873857 | Kriesel | Feb 1999 | A |
5875976 | Nelson et al. | Mar 1999 | A |
5879327 | Moreau DeFarges et al. | Mar 1999 | A |
5921966 | Bendek et al. | Jul 1999 | A |
6123684 | Deboer et al. | Sep 2000 | A |
6309371 | Deboer et al. | Oct 2001 | B1 |
6568259 | Saheki et al. | May 2003 | B2 |
6673035 | Rice et al. | Jan 2004 | B1 |
20020007149 | Nelson et al. | Jan 2002 | A1 |
Number | Date | Country |
---|---|---|
1181037 | May 1968 | GB |
WO 9910030 | Mar 1999 | WO |
Number | Date | Country | |
---|---|---|---|
20040134563 A1 | Jul 2004 | US |
Number | Date | Country | |
---|---|---|---|
60160893 | Oct 1999 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09692487 | Oct 2000 | US |
Child | 10743436 | US |